Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 25/06/23 → 24/06/25 |
Keywords
- Clinical trial
- DeLLphi-304
Clinical Trial Phase
- Phase III (a & b)
A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects with Relapsed Small Cell Lung Cancer After Platinum-based First-Line Chemotherapy (DeLLphi-304)
- Markman, Ben (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research